World Medicine Contract Manufacturing: Integration for Excellence
At World Medicine Limited (WML), we bring together the scale of a global pharmaceutical manufacturer, the agility of a dedicated contract partner, and the precision of a science-led organisation. From our headquarters in London, we coordinate a network of EU-GMP-approved facilities, strategically located to serve both established and emerging markets.
A Global Manufacturing Network
Our manufacturing footprint is designed for both resilience and efficiency. In Türkiye, our three EU-GMP certified plants form the heart of our production capability, supported by specialised facilities in Romania for food supplements and vitamins, and in Algeria for solid, liquid, and nasal dosage forms serving the MENA region. At the centre of this network is our flagship Cerkezkoy facility — a 50,000 m² integrated site that stands among the most advanced pharmaceutical plants in Europe.
Here, 13,000 m² of production space, 2,800 m² of ISO-accredited quality control laboratories, and 5,350 m² of temperature-controlled warehousing operate under a single, harmonised quality system. This configuration allows us to unite sterile and non-sterile production, packaging, and storage under one roof, delivering unparalleled operational efficiency and reducing the time between manufacture and market release.
Capacity Built for Reliability
The scale of our Cerkezkoy site allows us to support both niche market products and high-volume commercial campaigns. Multiple warehouse zones cater to different storage needs, from ambient and humidity-controlled spaces to cool rooms, cold rooms, and deep freezers capable of reaching –20°C.
We have the expertise and equipment to manufacture a broad range of dosage forms to the highest quality standards. Our sterile operations include small- and large-volume vials, lyophilised injectables, ampoules, and ophthalmic products, with high-speed filling lines and automated loading/unloading freeze dryers to support large-scale campaigns. For non-sterile products, we produce syrups, oral solutions, nasal sprays, creams, gels, ointments, suppositories, and other semi-solid forms using advanced homogenisation, heating, cooling, and filtration systems, all governed by SCADA-controlled recipes for precision and reproducibility.
Unlike many CMOs, we also control a critical part of the supply chain: the primary packaging production. Through our operation, we manufacture vials and ampoules on site, with an annual output of over 178 million units in amber and clear Type I glass. This in-house capability ensures consistent quality, reliable availability, and complete alignment between component and product specifications.
Our secondary packaging lines are equally advanced, featuring integrated vision systems, pharmacode readers, check-weighing, serialisation, and aggregation. Whether packaging vials, ampoules, bottles, or tubes, we maintain full compliance with global traceability and anti-counterfeiting requirements.
Regulatory Alignment for Multi-Market Access
We maintain a portfolio of GMP certifications that reflects our global reach and market versatility, including approvals from the Bulgarian Drug Agency (EU-GMP), Turkish Medicines and Medical Devices Agency (TMMDA), Eurasian Economic Union (EAEU), State Service of Ukraine on Medicines and Drugs Control (SMDC), UAE Ministry of Health and Prevention, and authorities in Uzbekistan, Uganda, and Rwanda. These certifications enable us to support simultaneous market launches across multiple regions, reducing duplication in regulatory submissions and accelerating access.
Integrated Model for Speed and Assurance
Our fully integrated approach — uniting manufacturing, quality control, packaging, storage, and global regulatory support — allows us to streamline technology transfers, scale up efficiently, and deliver products to market faster. This integration not only reduces operational risk but also enhances transparency, as every stage of the process is managed within our own network under a unified quality system.
From first batch to full-scale commercialisation, we operate as an extension of our partners’ teams, aligning our production schedules, quality expectations, and regulatory strategies to their needs. This collaborative approach has made us a trusted manufacturing partner for both multinational innovators and regional pharmaceutical leaders.
